Palex
Who owns Palex?
Palex is a Spanish MedTech company, now owned by Fremman Capital, NiXEN and 1 other, which acquired it in 2021 from Apheon.
Hand-verified · updated 2026-09-30
Open JSON · CC-BY- ·Co-held by Ardian and NiXEN since 2021.
- ·Average hold across 2 realized cycles: 3 years.
- ·4 distinct PE sponsors across ownership cycles.
Ownership history
5 ownership periods · co-invest detected
Corpfin Capital sold Palex to Ergon Capital in 2020 after 4 years.
Apheon sold Palex to Fremman Capital in 2021 after 1 year.
More from NiXEN II
Other portfolio companies in the same fund.
More PE-backed in MedTech
Comparable medtech deals from other GPs.
Questions
Who owns Palex?
Palex is now owned by Fremman Capital, NiXEN and 1 other, which acquired it in 2021 from Apheon.
When did Fremman Capital and 2 others acquire Palex?
Fremman Capital and 2 others acquired Palex in 2021, buying from Apheon.
Who did Palex sell to?
Apheon sold Palex to Fremman Capital in 2021 (Secondary). Corpfin Capital sold Palex to Ergon Capital in 2020 (Secondary).
Who has owned Palex over time?
Palex has been through 5 private-equity ownership periods: Corpfin Capital · via Corpfin Capital Fund IV · 2016–2020 · sold to Ergon Capital · (Secondary); Apheon · via AMB IV · 2020–2021 · sold to Fremman Capital · (Secondary); Ardian · via Ardian Co-Investment Fund V · since 2021; Ardian · via Ardian Co-Investment Fund VI · since 2023; NiXEN · via NiXEN II · since 2024.